Literature DB >> 18954698

The coagulant response in sepsis.

Marcel Levi1.   

Abstract

Sepsis is often associated with systemic intravascular activation of coagulation, potentially leading to widespread microvascular deposits of fibrin, and thereby contributing to multiple organ dysfunction. A complex interaction exists between activation of inflammatory systems and the initiating and regulating pathways of coagulation. A diagnosis of sepsis-associated disseminated intravascular coagulation can be made by a combination of routinely available laboratory tests, for which simple diagnostic algorithms have become available. Strategies to inhibit coagulation activation may theoretically be justified and are being evaluated in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954698     DOI: 10.1016/j.ccm.2008.06.006

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  35 in total

Review 1.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Erxi Wu; Martin Sillesen; George C Velmahos; Ihab Halaweish; Hasan B Alam
Journal:  Surgery       Date:  2014-06-21       Impact factor: 3.982

3.  Fructose-1,6-bisphosphate reduces the mortality in Candida albicans bloodstream infection and prevents the septic-induced platelet decrease.

Authors:  Roberto Christ Vianna Santos; Rafael Noal Moresco; Miguel Angel Peña Rico; Antonio R García Susperregui; Jose Luis Rosa; Ramon Bartrons; Francesc Ventura; Débora Nunes Mário; Sydney Hartz Alves; Etiane Tatsch; Helena Kober; Ricardo Obalski de Mello; Patrícia Scherer; Henrique Bregolin Dias; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

Review 4.  The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.

Authors:  Karen M Hook; Charles S Abrams
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

Review 5.  Changing Definitions of Sepsis.

Authors:  Fethi Gül; Mustafa Kemal Arslantaş; İsmail Cinel; Anand Kumar
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

6.  Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain.

Authors:  Jyotika Sharma; Chris A Mares; Qun Li; Elizabeth G Morris; Judy M Teale
Journal:  Microb Pathog       Date:  2011-04-01       Impact factor: 3.738

Review 7.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

8.  Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy.

Authors:  Marcel Levi; Jean-Louis Vincent; Kosuke Tanaka; Amanda H Radford; Toshihiko Kayanoki; David A Fineberg; Debra Hoppensteadt; Jawed Fareed
Journal:  Crit Care Med       Date:  2020-06-11       Impact factor: 7.598

9.  Infections of respiratory or abdominal origin in ICU patients: what are the differences?

Authors:  Elena Volakli; Claudia Spies; Argyris Michalopoulos; A B Johan Groeneveld; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

10.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.